Diagnosis and treatment of migraine in the patient with depression

Published on Nov 1, 2018in Journal of the American Association of Nurse Practitioners1.42
· DOI :10.1097/JXX.0000000000000075
Calli Cook3
Estimated H-index: 3
(Emory University),
Glenn Clinton Shedd1
Estimated H-index: 1
(Emory University)
ABSTRACTBackground and purpose:Migraine headache is an enormous health care burden resulting in billions of dollars in workforce revenue lost and millions of lost workdays per year. Migraine headaches and depression are common comorbidities and require expertise in treatment and prevention.Methods:T
📖 Papers frequently viewed together
14 Citations
18 Citations
Premise Migraine is a common and potentially debilitating chronic neurologic disorder, with significant and clinically important psychiatric co-morbidities. Problem The individual and societal impact of migraine is both significant and diverse, and among these effects are a variety of psychiatric co-morbidities. Although the precise mechanisms underlying the relationships between migraine and psychiatric illness are not entirely clear, a variety of mood and anxiety disorders have not only been i...
10 CitationsSource
#1Lanfranco Pellesi (University of Modena and Reggio Emilia)H-Index: 10
#2Simona Guerzoni (University of Modena and Reggio Emilia)H-Index: 14
Last. Luigi Alberto Pini (University of Modena and Reggio Emilia)H-Index: 27
view all 3 authors...
Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem; along with medication-induced (medication-overuse) headache, it is the third-leading cause of disability worldwide. Currently, its therapeutic management remains unsatisfactory for several reasons; up to 40% of migraineurs are eligible for prophylactic treatment, but there are issues of efficacy, safety, and adherence. In recent years the evidence on the role of calcitonin gene-related peptide (CG...
38 CitationsSource
Migraine is a complex, debilitating neurovascular disorder, typically characterized by recurring, incapacitating attacks of severe headache often accompanied by nausea and neurological disturbances. It has a strong genetic basis demonstrated by rare migraine disorders caused by mutations in single genes (monogenic), as well as familial clustering of common migraine which is associated with polymorphisms in many genes (polygenic). Hemiplegic migraine is a dominantly inherited, severe form of migr...
57 CitationsSource
#1Peter J. GoadsbyH-Index: 137
#2Philip R. Holland (UCSF: University of California, San Francisco)H-Index: 30
Last. Simon Akerman (UCSF: University of California, San Francisco)H-Index: 33
view all 6 authors...
Plaguing humans for more than two millennia, manifest on every continent studied, and with more than one billion patients having an attack in any year, migraine stands as the sixth most common cause of disability on the planet. The pathophysiology of migraine has emerged from a historical consideration of the "humors" through mid-20th century distraction of the now defunct Vascular Theory to a clear place as a neurological disorder. It could be said there are three questions: why, how, and when?...
553 CitationsSource
#1Taeho Greg Rhee (UMN: University of Minnesota)H-Index: 14
#2Ila M. HarrisH-Index: 12
Objective We examined whether the prevalence of complementary and alternative medicine (CAM) use varies by gender, and assessed the interaction of gender and CAM use on moderate mental distress (MMD) in U.S. adults with migraines/severe headaches. Methods We used data from the 2012 National Health Interview Survey, which represents non-institutionalized U.S. adults with migraines/severe headaches (n = 4645 unweighted). Using a cross-sectional design with survey sampling techniques, we conducted ...
25 CitationsSource
#1Tamara Pringsheim (U of C: University of Calgary)H-Index: 55
#2William Jeptha Davenport (U of C: University of Calgary)H-Index: 3
Last. Stephen D. SilbersteinH-Index: 109
view all 5 authors...
The "Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies" provides levels of evidence for medication efficacy for acute treatment of migraine. The goal of this companion paper is to provide guidance on how to choose between evidence-based treatment options, and, based on the clinical characteristics of the patient and their migraine attacks, to provide guidance on designing an individualized strategy for managing migraine attacks...
14 CitationsSource
#1Serena L. Orr (U of O: University of Ottawa)H-Index: 10
#1Serena L. Orr (U of O: University of Ottawa)H-Index: 6
Last. Deborah TepperH-Index: 12
view all 7 authors...
Objective To provide evidence-based treatment recommendations for adults with acute migraine who require treatment with injectable medication in an emergency department (ED). We addressed two clinically relevant questions: (1) Which injectable medications should be considered first-line treatment for adults who present to an ED with acute migraine? (2) Do parenteral corticosteroids prevent recurrence of migraine in adults discharged from an ED? Methods The American Headache Society convened an e...
100 CitationsSource
#1David M. SimpsonH-Index: 24
#1David M. Simpson (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 64
Last. Stuart A. YablonH-Index: 37
view all 14 authors...
Objective: To update the 2008 American Academy of Neurology (AAN) guidelines regarding botulinum neurotoxin for blepharospasm, cervical dystonia (CD), headache, and adult spasticity. Methods: We searched the literature for relevant articles and classified them using 2004 AAN criteria. Results and recommendations: Blepharospasm: OnabotulinumtoxinA (onaBoNT-A) and incobotulinumtoxinA (incoBoNT-A) are probably effective and should be considered (Level B). AbobotulinumtoxinA (aboBoNT-A) is possibly ...
245 CitationsSource
Background Blau theorized that migraine triggers are exposures that in higher amounts would damage the brain. The recent discovery that the TRPA1 ion channel transduces oxidative stress and triggers neurogenic inflammation suggests that oxidative stress may be the common denominator underlying migraine triggers. Objective The aim of this review is to present and discuss the available literature on the capacity of common migraine triggers to generate oxidative stress in the brain. Methods A Medli...
96 CitationsSource
#1Stewart J. TepperH-Index: 8
Purpose of Review:Nutraceutical, biobehavioral, and physical treatments, including complementary and alternative medicines, may benefit patients with migraine and other headache disorders. This article summarizes the evidence for the use of these therapies with discussion on evidence quality and pro
21 CitationsSource
Cited By2
#1Todd A. Smitherman (University of Mississippi)H-Index: 27
#2Gretchen E. Tietjen (UT: University of Toledo)H-Index: 38
Last. Eric M Pearlman (Eli Lilly and Company)H-Index: 6
view all 7 authors...
OBJECTIVE This post hoc analysis evaluated the efficacy of galcanezumab for the prevention of migraine in patients with and without comorbid anxiety and/or depression. BACKGROUND Patients with migraine have a higher risk of anxiety and/or depression. Given the high prevalence of psychiatric symptoms and their potential negative prognostic impact, determining the efficacy of migraine treatments in patients with these comorbidities is important. METHODS The results of 2 phase 3 episodic migraine s...
#1Xiao BaoH-Index: 2
#2Howe Liu (University of North Texas Health Science Center)H-Index: 3
Last. Zhi-Min ZhuH-Index: 1
view all 6 authors...
Objective To study the effect of intermittent hypoxia training (IHT) for migraine. Design A single-blind, randomized controlled trial. All participants were recruited from a rehabilitation department in an acute university-affiliated hospital. Methods Participants with migraines were randomly assigned to two groups (IHT group and control group). The Migraine Disability Assessment (MIDAS), Visual Analog Scale (VAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Vascular endotheli...
1 Citations